PI Industries Annual Report Analysis - Preparing For The Future: Nirmal Bang
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Nirmal Bang Report
PI Industries Ltd.’s FY21 annual report reveals that the agrochem focused company’s future growth hinges on the recently acquired pharma business, the domestic crop protection chemicals formulation business and the horticulture subsidiary Jivagro (carved out of the India-focused business-to-consumer vertical post the Isagro Asia acquisition).
This will be complemented by its core custom synthesis manufacturing vertical, based on increased capacity utilisation from the two new multi-product plants (including the one added in Q2 FY22) as well as Isagro’s manufacturing assets for agri Inputs/CSM.
Overall, PI Industries' management discussion and analysis is positive on long term growth prospects in domestic crop protection chemical/exports.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.